Detalhe da pesquisa
1.
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Gynecol Oncol
; 187: 198-203, 2024 May 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38795508
2.
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Am J Obstet Gynecol
; 228(4): 440.e1-440.e20, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36403862
3.
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
BJOG
; 130(8): 968-977, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36715559
4.
Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study.
BMC Cancer
; 22(1): 445, 2022 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35461213
5.
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.
Support Care Cancer
; 30(4): 3409-3418, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34997316
6.
Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.
Gynecol Oncol
; 161(1): 202-210, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33514483
7.
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Gynecol Oncol
; 163(2): 371-377, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34456057
8.
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial.
Gynecol Oncol
; 159(3): 672-680, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33041071
9.
A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.
Health Expect
; 21(3): 659-667, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29281161
10.
Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.
Gynecol Oncol
; 146(3): 449-456, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28645428
11.
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 115(10): 1174-1178, 2016 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27755534
12.
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
Mod Pathol
; 29(7): 753-63, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27056074
13.
Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible.
Gynecol Oncol
; 140(3): 415-9, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26797295
14.
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
Int J Gynecol Cancer
; 26(1): 43-51, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26588231
15.
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
BMC Cancer
; 15: 593, 2015 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-26286255
16.
Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature.
Gynecol Oncol
; 136(1): 143-57, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25448458
17.
Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
Gynecol Oncol
; 139(3): 458-64, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26432039
18.
Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.
Int J Gynecol Cancer
; 25(6): 1086-93, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25768079
19.
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.
BMC Cancer
; 14: 22, 2014 Jan 14.
Artigo
Inglês
| MEDLINE | ID: mdl-24422892
20.
CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
Gynecol Oncol
; 135(1): 149-55, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25072932